Genetic Markers of Graves’ Disease: A Historical View and Up-date

References (257)

1. 1 Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results [DOI]
2. 2 Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse [DOI]
3. 3 Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease [DOI]
4. 4 A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes [DOI]
5. 5 Haplotype tagging for the identification of common disease genes [DOI]
6. 6 Scavenger receptors: role in innate immunity and microbial pathogenesis [DOI]
7. 7 A genome-wide association study identifies two new risk loci for Graves' disease [DOI]
8. 8 The autoimmune disease–associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness [DOI]
9. 9 The HLA gene complex in thyroid autoimmunity: From epidemiology to etiology [DOI]
10. 10 Cutting Edge: A Soluble Form of CTLA-4 in Patients with Autoimmune Thyroid Disease [DOI]
11. 11 A CTLA-4 gene polymorphism at position −318 in the promoter region affects the expression of protein [DOI]
12. 12 Cytotoxic T-Lymphocyte Associated Antigen 4 Gene Polymorphisms and Autoimmune Thyroid Disease: A Meta-Analysis [DOI]
13. 13 PTPN22 Deficiency Cooperates with the CD45 E613R Allele to Break Tolerance on a Non-Autoimmune Background [DOI]
14. 14 Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves’ disease in a Polish population: association and gene dose‐dependent correlation with age of onset [DOI]
15. 15 The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity. [DOI]
16. 16 Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease [DOI]
17. 17 The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: An association analysis in Caucasian and Japanese cohorts [DOI]
18. 18 Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases [DOI]
19. 19 FCRL3, an Autoimmune Susceptibility Gene, Has Inhibitory Potential on B-Cell Receptor-Mediated Signaling [DOI]
20. 20 Expression of the Autoimmune Susceptibility Gene FcRL3 on Human Regulatory T Cells Is Associated with Dysfunction and High Levels of Programmed Cell Death-1 [DOI]
21. 21 Cloning and sequencing of a 1.3 kb variant of human thyrotropin receptor mRNA lacking the transmembrane domain [DOI]
22. 22 Fc Receptor-Like 3 Protein Expressed on IL-2 Nonresponsive Subset of Human Regulatory T Cells [DOI]
23. 23 Genetic analysis and functional evaluation of the C/T(−318) and A/G(−1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease [DOI]
24. 24 Association of Autoimmune Thyroid Disease with Microsatellite Markers for the Thyrotropin Receptor Gene and CTLA-4 in Japanese Patients [DOI]
25. 25 Regulatory T cells in Graves’ disease [DOI]
26. 26 Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis [DOI]
27. 27 A Variant of the Il2ra / Cd25 Gene Predisposing to Graves’ Disease is Associated with Increased Levels of Soluble Interleukin‐2 Receptor [DOI]
28. 28 Technological Issues and Experimental Design of Gene Association Studies [DOI]
29. 29 Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. [DOI]
30. 30 HLA ANTIGENS IN GRAVES' DISEASE [DOI]
31. 31 Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. [DOI]
32. 32 CTLA-4 and Not CD28 Is a Susceptibility Gene for Thyroid Autoantibody Production1 [DOI]
33. 33 The Living City
34. 34 A Polymorphism in the Human UGRP1 Gene Promoter That Regulates Transcription Is Associated with an Increased Risk of Asthma [DOI]
35. 35 Room for manoeuvre? [DOI]
36. 36 IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility [DOI]
37. 37 Thyroid-stimulating hormone receptor and its role in Graves’ disease [DOI]
38. 38 HLA and CTLA4 polymorphisms may confer a synergistic risk in the susceptibility to Graves’ disease [DOI]
39. 39 Association of Fc receptor‐like 5 (FCRL5) with Graves’ disease is secondary to the effect of FCRL3 [DOI]
40. 40 Old wine in new bottles? An overview of Africa's urban problems and the "urban management" approach to dealing with them. [DOI]
41. 41 CTLA-4 AT-Repeat Polymorphism Reduces the Inhibitory Function of CTLA-4 in Graves' Disease [DOI]
42. 42 The Introduction and Conclusion [DOI]
43. 43 Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
44. 44 Functional analysis of a variant of the thyrotropin receptor gene in a family with Graves' disease [DOI]
45. 45 Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23–q32, for susceptibility to Graves’ disease: a TDT study [DOI]
46. 46 Habitat International Coalition [DOI]
47. 47 Fine-Mapping Chromosome 20 in 230 Systemic Lupus Erythematosus Sib Pair and Multiplex Families: Evidence for Genetic Epistasis with Chromosome 16q12 [DOI]
48. 48 The 'tugurios' of San Salvador: a place to live, work and struggle [DOI]
49. 49 Community Development Corporations [DOI]
50. 50 Heredity in graves' disease : with remarks on heredity in toxic adenoma in the thyroid, non-toxic goitre, and myxoedema
51. 51 A Missense Single-Nucleotide Polymorphism in a Gene Encoding a Protein Tyrosine Phosphatase (PTPN22) Is Associated with Rheumatoid Arthritis [DOI]
52. 52 Reversal of the TCR Stop Signal by CTLA-4 [DOI]
53. 53 Common variants at CD40 and other loci confer risk of rheumatoid arthritis [DOI]
54. 54 PEST Domain-Enriched Tyrosine Phosphatase (PEP) Regulation of Effector/Memory T Cells [DOI]
55. 55 CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms [DOI]
56. 56 Localization of a Type 1 Diabetes Locus in the IL2RA/CD25 Region by Use of Tag Single-Nucleotide Polymorphisms [DOI]
57. 57 A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells [DOI]
58. 58 Ethnic differences in allele frequency of autoimmune-disease-associated SNPs [DOI]
59. 59 Common and Unique Susceptibility Loci in Graves and Hashimoto Diseases: Results of Whole-Genome Screening in a Data Set of 102 Multiplex Families [DOI]
60. 60 Interleukin-2 receptor signaling in regulatory T cell development and homeostasis [DOI]
61. 61 Protein tyrosine phosphatase PTPN22 in human autoimmunity [DOI]
62. 62 CD40/CD40L signaling and its implication in health and disease [DOI]
63. 63 Association of the interleukin‐2 receptor alpha (IL‐2Rα)/CD25 gene region with Graves’ disease using a multilocus test and tag SNPs [DOI]
64. 64 The regulation of Foxp3 expression in regulatory CD4+CD25+T cells: Multiple pathways on the road [DOI]
65. 65 Thyroglobulin Is a Thyroid Specific Gene for the Familial Autoimmune Thyroid Diseases [DOI]
66. 66 The Genetics of Autoimmune Thyroid Disease [DOI]
67. 67 A population‐based study of Graves' disease in Danish twins [DOI]
68. 68 IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells [DOI]
69. 69 Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis [DOI]
70. 70 Contribution of Single Nucleotide Polymorphisms withinFCRL3andMAP3K7IP2to the Pathogenesis of Graves’ Disease [DOI]
71. 71 Primary role of the HLA class II DRB1*0301 allele in graves disease [DOI]
72. 72 Association of APOEpolymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study [DOI]
73. 73 The Codon 620 Single Nucleotide Polymorphism of the Protein Tyrosine Phosphatase-22 Gene Does not Contribute to Autoimmune Thyroid Disease Susceptibility in the Japanese [DOI]
74. 74 New B-cell CD molecules [DOI]
75. 75 Association of CD40 Gene Polymorphism (C-1T) with Susceptibility and Phenotype of Graves' Disease [DOI]
76. 76 The Genetics of Graves’ Disease: HLA and Disease Susceptibility* [DOI]
77. 77 GRAVES' DISEASE AND HLA: CLINICAL AND EPIDEMIOLOGIC ASSOCIATIONS [DOI]
78. 78 Linkage Analysis of Candidate Genes in Autoimmune Thyroid Disease. II. Selected Gender-Related Genes and the X-Chromosome [DOI]
79. 79 HLA-DRB1108, DRB1103/DRB310101, and DRB310202 Are Susceptibility Genes for Graves’ Disease in North American Caucasians, Whereas DRB1107 Is Protective1 [DOI]
80. 80 Association of a Rare Thyroglobulin Gene Microsatellite Variant with Autoimmune Thyroid Disease [DOI]
81. 81 Possible Interaction Between HLA-DR β 1 and Thyroglobulin Variants in Graves' Disease [DOI]
82. 82 Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3′ +6230G>A polymorphism [DOI]
83. 83 The crucial role of IL-2/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies [DOI]
84. 84 Association of the thyroglobulin gene polymorphism with autoimmune thyroid disease in Chinese population [DOI]
85. 85 Employing a Recombinant HLA-DR3 Expression System to Dissect Major Histocompatibility Complex II-Thyroglobulin Peptide Dynamism [DOI]
86. 86 Association between Fc receptor-like 3 C169T polymorphism and risk of systemic lupus erythematosus: a meta-analysis [DOI]
87. 87 The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseases [DOI]
88. 88 Genetics of Type 1 Diabetes and Autoimmune Thyroid Disease [DOI]
89. 89 Thyrotropin Receptor Polymorphisms and Thyroid Diseases [DOI]
90. 90 Lack of Association Between Polymorphism of the Thyrotropin Receptor Gene and Graves' Disease in United Kingdom and Hong Kong Chinese Patients: Case Control and Family-Based Studies [DOI]
91. 91 A Roadmap for HLA-DR Peptide Binding Specificities [DOI]
92. 92 A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD‐2) provides no evidence for susceptibility to Graves’ disease in UK Caucasians [DOI]
93. 93 Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012–1704) of the TSH receptor gene in Graves’ disease [DOI]
94. 94 Exon 33 T/T genotype of the thyroglobulin gene is a susceptibility gene for Graves’ disease in Taiwanese and exon 12 C/C genotype protects against it [DOI]
95. 95 Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders [DOI]
96. 96 Biochemical analysis of CTLA-4 immunoreactive material from human blood [DOI]
97. 97 Socially responsible capitalism [DOI]
98. 98 HL-A Antigens as Markers for Disease Susceptibility and Autoimmunity in Graves' Disease [DOI]
99. 99 The Association of HLA with Autoimmune Thyroid Disease in Newfoundland. The Influence of HLA Homozygosity in Graves’ Disease [DOI]
100. 100 Further Evidence for a Susceptibility Locus on Chromosome 20q13.11 in Families with Dominant Transmission of Graves Disease [DOI]
101. 101 The Future of Genetic Studies of Complex Human Diseases [DOI]
102. 102 The Wellcome Trust Case Control Consortium, U.K. [DOI]
103. 103 HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus [DOI]
104. 104 Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4 [DOI]
105. 105 Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants [DOI]
106. 106 A genome-wide search for human type 1 diabetes susceptibility genes [DOI]
107. 107 Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant [DOI]
108. 108 Genetic Association of the R620W Polymorphism of Protein Tyrosine Phosphatase PTPN22 with Human SLE [DOI]
109. 109 Overview of interleukin-2 function, production and clinical applications [DOI]
110. 110 CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. [DOI]
111. 111 Evidence for a Major Role of Heredity in Graves’ Disease: A Population-Based Study of Two Danish Twin Cohorts1 [DOI]
112. 112 CTLA4 Alanine-17 Confers Genetic Susceptibility to Graves’ Disease and to Type 1 Diabetes Mellitus1 [DOI]
113. 113 A Common Autoimmunity Predisposing Signal Peptide Variant of the Cytotoxic T-lymphocyte Antigen 4 Results in Inefficient Glycosylation of the Susceptibility Allele [DOI]
114. 114 CTLA4 gene polymorphism and autoimmunity [DOI]
115. 115 IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production [DOI]
116. 116 PTPN22 Genetic Variation: Evidence for Multiple Variants Associated with Rheumatoid Arthritis [DOI]
117. 117 Genetic Susceptibility to Autoimmune Thyroid Disease: Past, Present, and Future [DOI]
118. 118 Autoimmune Thyroid Disease [DOI]
119. 119 Multiple SNPs in Intron 7 of Thyrotropin Receptor Are Associated with Graves’ Disease [DOI]
120. 120 Regulatory T cells and autoimmune disease [DOI]
121. 121 Mapping the Major Susceptibility Loci for Familial Graves’ and Hashimoto’s Diseases: Evidence for Genetic Heterogeneity and Gene Interactions1 [DOI]
122. 122 Arginine at position 74 of the HLA-DR β1 chain is associated with Graves' disease [DOI]
123. 123 Regression Mapping of Association between the Human Leukocyte Antigen Region and Graves Disease [DOI]
124. 124 Association ofPTPN22Haplotypes with Graves’ Disease [DOI]
125. 125 Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice [DOI]
126. 126 Ethnogenetic heterogeneity of rheumatoid arthritis—implications for pathogenesis [DOI]
127. 127 Analysis of the Fc Receptor-Like-3 (FCRL3) Locus in Caucasians with Autoimmune Disorders Suggests a Complex Pattern of Disease Association [DOI]
128. 128 Is FCRL3 a New General Autoimmunity Gene? [DOI]
129. 129 CD8+CD122+ T Cells, a Newly Identified Regulatory T Subset, Negatively Regulate Graves’ Hyperthyroidism in a Murine Model [DOI]
130. 130 CD4+CD25+ naturally occurring regulatory T cells and not lymphopenia play a role in the pathogenesis of iodide-induced autoimmune thyroiditis in NOD-H2h4 mice [DOI]
131. 131 Association of a C/T Single-Nucleotide Polymorphism in the 5' Untranslated Region of the CD40 Gene with Graves' Disease in Japanese [DOI]
132. 132 Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases [DOI]
133. 133 Thyroid Stimulating Hormone Receptor (TSHR) Intron 1 Variants Are Major Risk Factors for Graves' Disease in Three European Caucasian Cohorts [DOI]
134. 134 CTLA‐4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis [DOI]
135. 135 Soluble interleukin-2 receptor in cancer [DOI]
136. 136 Confirmation of Association of Chromosome 5q31–33 with United Kingdom Caucasian Graves' Disease [DOI]
137. 137 Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies. [DOI]
138. 138 A New Graves Disease–Susceptibility Locus Maps To Chromosome 20q11.2 [DOI]
139. 139 A Polymorphism in the Extracellular Domain of the Thyrotropin Receptor Is Highly Associated with Autoimmune Thyroid Disease in Females [DOI]
140. 140 Genetic Factors in Autoimmune Thyroid Disease Analyzed by Restriction Fragment Length Polymorphisms of Candidate Genes* [DOI]
141. 141 Association of HLA‐DQA1*0501 with Graves’ disease in English Caucasian men and women [DOI]
142. 142 Genome-Wide Scan of Graves’ Disease: Evidence for Linkage on Chromosome 5q31 in Chinese Han Pedigrees [DOI]
143. 143 Association between a C/T Polymorphism in Exon 33 of the Thyroglobulin Gene Is Associated with Relapse of Graves’ Hyperthyroidism after Antithyroid Withdrawal in Taiwanese [DOI]
144. 144 Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients [DOI]
145. 145 Changes of regulatory T cells in Graves’ disease [DOI]
146. 146 No Association between a Thyrotropin Receptor Gene Polymorphism and Graves' Disease in the Female Population [DOI]
147. 147 The −112G > A polymorphism of the secretoglobin 3A2 (SCGB3A2) gene encoding uteroglobin-related protein 1 (UGRP1) increases risk for the development of Graves’ disease in subsets of patients with elevated levels of immunoglobulin E [DOI]
148. 148 Analysis of Mutations in Exon 1 of the Human Thyrotropin Receptor Gene: High Frequency of the D36H and P52T Polymorphic Variants [DOI]
149. 149 Multiple Messenger Ribonucleic Acid Transcripts and Revised Gene Organization of the Human TSH Receptor. [DOI]
150. 150 Recognition of altered self major histocompatibility complex molecules modulated by specific peptide interactions [DOI]
151. 151 Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls [DOI]
152. 152 Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome [DOI]
153. 153 Whole-Genome Sequencing in a Patient with Charcot–Marie–Tooth Neuropathy [DOI]
154. 154 Analysis of Families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) Collection: the PTPN22 620W Allele Associates with Multiple Autoimmune Phenotypes [DOI]
155. 155 Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 [DOI]
156. 156 A map of human genome variation from population-scale sequencing [DOI]
157. 157 Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus [DOI]
158. 158 The Codon 620 Tryptophan Allele of the Lymphoid Tyrosine Phosphatase (LYP) Gene Is a Major Determinant of Graves’ Disease [DOI]
159. 159 Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function [DOI]
160. 160 Genetic Variation in PTPN22 Corresponds to Altered Function of T and B Lymphocytes [DOI]
161. 161 The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation [DOI]
162. 162 The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis [DOI]
163. 163 A Graves’ Disease-Associated Kozak Sequence Single-Nucleotide Polymorphism Enhances the Efficiency of CD40 Gene Translation: A Case for Translational Pathophysiology [DOI]
164. 164 A C/T Single-Nucleotide Polymorphism in the Region of the CD40 Gene is Associated with Graves' Disease [DOI]
165. 165 The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim [DOI]
166. 166 Cutting Edge: The PTPN22 Allelic Variant Associated with Autoimmunity Impairs B Cell Signaling [DOI]
167. 167 Soluble IL-2RA Levels in Multiple Sclerosis Subjects and the Effect of Soluble IL-2RA on Immune Responses [DOI]
168. 168 Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese [DOI]
169. 169 Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease [DOI]
170. 170 Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals [DOI]
171. 171 The thymus and central tolerance [DOI]
172. 172 Regulation of Graves’ Hyperthyroidism with Naturally Occurring CD4+CD25+ Regulatory T Cells in a Mouse Model [DOI]
173. 173 Clinical associations of the genetic variants of CTLA‐4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves’ disease [DOI]
174. 174 A Haplotype-Based Analysis of the PTPN22 Locus in Type 1 Diabetes [DOI]
175. 175 Thyroid Autoimmunity and Environment [DOI]
176. 176 Functional SNPs in the SCGB3A2 promoter are associated with susceptibility to Graves' disease [DOI]
177. 177 Linkage Disequilibrium between the Human Leukocyte Antigen Class II Region of the Major Histocompatibility Complex and Graves’ Disease: Replication Using a Population Case Control and Family-Based Study1 [DOI]
178. 178 The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA‐DR3 positive AITD families [DOI]
179. 179 A Genome-Wide Screen in 1119 Relative Pairs with Autoimmune Thyroid Disease [DOI]
180. 180 A C/T Polymorphism in the 5′-Untranslated Region of the CD40 Gene is Associated with Graves' Disease in Koreans [DOI]
181. 181 Association of the Cytotoxic T Lymphocyte-Associated Antigen 4 Gene with Type 1 Diabetes: Evidence for Independent Effects of Two Polymorphisms on the Same Haplotype Block [DOI]
182. 182 Association Analysis of CD40 Polymorphisms with Asthma and the Level of Serum Total IgE [DOI]
183. 183 Detection of CD40 on Human Thyroid Follicular Cells: Analysis of Expression and Function1 [DOI]
184. 184 The Influence of the Exon 1 Polymorphism of the Cytotoxic T Lymphocyte Antigen 4 Gene on Thyroid Antibody Production in Patients with Newly Diagnosed Graves' Disease [DOI]
185. 185 Association of Graves' Disease with Intragenic Polymorphism of the Thyrotropin Receptor Gene in a Cohort of Singapore Patients of Multi-Ethnic Origins [DOI]
186. 186 A Germline Single Nucleotide Polymorphism at the Intracellular Domain of the Human Thyrotropin Receptor Does Not Have a Major Effect on the Development of Graves' Disease [DOI]
187. 187 Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population [DOI]
188. 188 Tg.2098 is a major human thyroglobulin T-cell epitope [DOI]
189. 189 Complex Association Analysis of Graves Disease Using a Set of Polymorphic Markers [DOI]
190. 190 Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy [DOI]
191. 191 Association study between the IL4, IL13, IRF1 and UGRP1 genes in chromosomal 5q31 region and Chinese Graves’ disease [DOI]
192. 192 PTPN22 allele polymorphisms in 15 Chinese populations [DOI]
193. 193 CAATT/Enhancer-binding Proteins α and δ Interact with NKX2-1 to Synergistically Activate Mouse Secretoglobin 3A2 Gene Expression [DOI]
194. 194 CTLA-4 and autoimmune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4 [DOI]
195. 195 Plasma UGRP1 Levels Associate with Promoter G-112A Polymorphism and the Severity of Asthma [DOI]
196. 196 Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease. [DOI]
197. 197 Autoimmune Thyroid Disease Genes Come in Many Styles and Colors1 [DOI]
198. 198 Serum cytokine levels in autoimmune and non-autoimmune hyperthyroid states [DOI]
199. 199 Single-step capture and sequencing of natural DNA for detection of BRCA1 mutations [DOI]
200. 200 Modulation of the IL-2 production defectin vitroin Graves'disease [DOI]
201. 201 A map of human genome variation from population-scale sequencing [DOI]
202. 202 A haplotype map of the human genome [DOI]
203. 203 The CD40 Antigen and its Ligand [DOI]
204. 204 CTLA-4 ligation blocks CD28-dependent T cell activation. [DOI]
205. 205 Cooperative Inhibition of T-Cell Antigen Receptor Signaling by a Complex between a Kinase and a Phosphatase [DOI]
206. 206 A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities [DOI]
207. 207 Fc Receptor-Like Molecules [DOI]
208. 208 The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim [DOI]
209. 209 Evidence for a Major Role of Heredity in Graves' Disease: A Population-Based Study of Two Danish Twin Cohorts [DOI]
210. 210 CTLA-4 and its role in autoimmune thyroid disease [DOI]
211. 211 Impairment of Regulatory Capacity of CD4+CD25+ Regulatory T Cells Mediated by Dendritic Cell Polarization and Hyperthyroidism in Graves’ Disease [DOI]
212. 212 Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease [DOI]
213. 213 Critical Role of MARCO in Crystalline Silica–Induced Pulmonary Inflammation [DOI]
214. 214 CTLA4 Alanine-17 Confers Genetic Susceptibility to Graves' Disease and to Type 1 Diabetes Mellitus [DOI]
215. 215 The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus [DOI]
216. 216 CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population [DOI]
217. 217 Association of the TSHR gene with Graves' disease: the first disease specific locus [DOI]
218. 218 The Link between Graves’ Disease and Hashimoto’s Thyroiditis: A Role for Regulatory T Cells [DOI]
219. 219 Linkage proof for PTPN22 , a rheumatoid arthritis susceptibility gene and a human autoimmunity gene [DOI]
220. 220 Polymorphism in the Promoter and Exon 1 of the Cytotoxic T Lymphocyte Antigen-4 Gene Associated with Autoimmune Thyroid Disease in Koreans [DOI]
221. 221 Genetic association studies of the FOXP3 gene in Graves’ disease and autoimmune Addison’s disease in the United Kingdom population [DOI]
222. 222 Non-governmental Organizations [DOI]
223. 223 The Development of Graves’ Disease and theCTLA-4Gene on Chromosome 2q331 [DOI]
224. 224 CTLA-4 and Not CD28 Is a Susceptibility Gene for Thyroid Autoantibody Production [DOI]
225. 225 The Development of Graves' Disease and the CTLA-4 Gene on Chromosome 2q33 [DOI]
226. 226 CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden [DOI]
227. 227 Thyroglobulin Is a Thyroid Specific Gene for the Familial Autoimmune Thyroid Diseases [DOI]
228. 228 Genetics of Endometriosis: A Review of the Positional Cloning Approaches [DOI]
229. 229 A C/T Polymorphism in the 5' Untranslated Region of the CD40 Gene Is Associated with Later Onset of Graves' Disease in Japanese [DOI]
230. 230 Detection of CD40 on Human Thyroid Follicular Cells: Analysis of Expression and Function [DOI]
231. 231 Autoimmune thyroid disease in childhood: a study of children and their families.
232. 232 The CD40 Antigen and Its Ligand [DOI]
233. 233 Role of the CD40 Locus in Graves' Disease [DOI]
234. 234 HLA-DRB108, DRB103/DRB30101, and DRB30202 Are Susceptibility Genes for Graves' Disease in North American Caucasians, Whereas DRB107 Is Protective [DOI]
235. 235 Urban Services in Developing Countries [DOI]
236. 236 Further studies of genetic susceptibility to Graves' disease in a Russian population.
237. 237 IMMUNOGENETICS OF GRAVES' OPHTHALMOPATHY [DOI]
238. 238 HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course [DOI]
239. 239 The thymus and central tolerance.
240. 240 DIFFERENTIATION OF AUTOIMMUNE OPHTHALMOPATHY FROM GRAVES’HYPERTHYROIDISM BY ANALYSIS OF GENETIC MARKERS [DOI]
241. 241 Thyrotropin Receptor Polymorphisms and Thyroid Diseases [DOI]
242. 242 Autoimmune Thyroid Disease Genes Come in Many Styles and Colors [DOI]
243. 243 RENTAL HOUSING IN DEVELOPING COUNTRIES: ISSUES AND CONSTRAINTS
244. 244 The Genetics of Autoimmune Thyroid Disease [DOI]
245. 245 Co-operative housing
246. 246 3. The Urban Housing Market [DOI]
247. 247 4. The Collapse of the Welfare Consensus? The Welfare State in the 1980s [DOI]
248. 248 Self-Help
249. 249 Community-Based Organizations [DOI]
250. 250 8. The Municipal Role in Housing the Homeless and Poor [DOI]
251. 251 Analysis of Human Genetic Linkage [DOI]
252. 252 Mapping the Major Susceptibility Loci for Familial Graves' and Hashimoto's Diseases: Evidence for Genetic Heterogeneity and Gene Interactions [DOI]
253. 253 Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population [DOI]
254. 254 A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells [DOI]
255. 255 Linkage Disequilibrium between the Human Leukocyte Antigen Class II Region of the Major Histocompatibility Complex and Graves' Disease: Replication Using a Population Case Control and Family-Based Study [DOI]
256. 256 DIFFERENTIATION OF AUTOIMMUNE OPHTHALMOPATHY FROM GRAVES’ HYPERTHYROIDISM BY ANALYSIS OF GENETIC MARKERS [DOI]
257. 257 IMMUNOGENETICS OF GRAVES’ OPHTHALMOPATHY [DOI]

Cited by 6

Showing 5 of 6 known citations — external sources report more than can currently be individually listed.

Related research

• Prevalence of Hypertension among Diabetic Patients in Benghazi: A Study of Associated Factors — shares topic coverage
• The Prevalence of Irritable Bowel Syndrome (IBS) in a Private-University in Malaysia, and Its Associated Factors Including Stress, Depression and Anxiety — shares topic coverage
• Association of Bacteria with Fungal Infection of Skin and Soft Tissue Lesions in Plateau State, Nigeria — shares topic coverage
• Exploring the Relationship between Yield and Yield Attributing Traits in Advanced Breeding Lines of Rice (Oryza sativa L.) — shares topic coverage
• A Study on Farmers’ Attitude towards Soil Health Card in Rangareddy District, Telangana State, India — shares topic coverage